Bone Growth Stimulator Market – Global Overview and Forecast (2023-2029)

Bone Growth Stimulator Market size was valued at US$ 1.19 Bn. in 2022 and the total Bone Growth Stimulator revenue is expected to grow at 6.5 % through 2022 to 2029, reaching nearly US$ 1.82 Bn.
Bone Growth Stimulator Market Overview:
BGS or bone growth stimulation is a type of treatment that is frequently used to improve healing after a spinal fusion surgery or fracture. BGS may promote faster natural healing in fractures that would take a long time to heal on their own. A bone growth stimulator is a device that many orthopaedists recommend to encourage quicker bone repair. Stimulators provide painless electrical or ultrasonic stimulation to promote bone growth. Internal bone growth stimulators are implanted surgically. External bone growth stimulators are small, portable devices that may be worn on the outside of the body and are kept in place by straps. The rising awareness regarding the availability of innovative bone growth stimulators among patients with bone and joint disorders is contributing to the overall market revenue during the forecast period. To Know About The Research Methodology :- Request Free Sample Report

In this report, the Bone Growth Stimulator market's growth reasons, as well as the market's many segments (Product, End User, Application, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the Bone Growth Stimulator market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Bone Growth Stimulator market situation.
Bone Growth Stimulator Market Dynamics:
Patient's preference for non-invasive and minimally invasive surgical treatments is increasing.

The preference for minimally invasive procedures has significantly increased because of the advantages which these techniques have over standard treatment procedures. Minimally invasive operations provide several advantages, including fewer surgical problems, less hospitalization, less pain, a decreased risk of infection, less postoperative care, and faster recovery. The number of spinal and orthopedic treatments is increasing owing to the rising number of accidents and trauma patients.

This has resulted in a rise in demand for Bone Growth Stimulator. The BMP and PRP market is expected to rise at a high pace throughout the forecast period because of the rising frequency of joint pain, spinal injuries, and trauma and accident cases. Platelet-rich Plasma (PRP) and Bone Morphogenetic Proteins (BMP) procedures help for the growth of bones at a time of fracture healing and spinal surgery. It is expected that their use would increase as a result of speedier healing and recovery.

The introduction of innovative bone growth stimulation technologies is expected to boost market revenue.

Market key players are focusing on research and development to create novel bone growth stimulation devices. Bioventus, for example, has incorporated novel features in its Exogen bone healing system that allow the stimulation of the body's natural healing process while lowering the risk of infection and complication. As a result, the above factors are expected to have a major influence on market growth over the forecast period. Manufacturers are extensively spending on R&D activities, which allows them to develop and profit from these products, allowing them to create a great opportunity for the market.

Restraint for the Bone Growth stimulator market

The limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products will impede the market growth. However, the side effects associated with BMP-based orthopedic treatment will further challenge market growth during the forecast period.
Bone Growth Stimulator Market Segment Analysis:
By Product, an external electrical stimulator is typically lightweight and battery-powered, making it relatively portable. External electrical stimulation devices are thought to be quite safe. Patients can move around and go for their regular activities while using the device. The external device is not painful to the patient, and the user will not experience any electrical shocks or vibrations while wearing it.

Ultrasonic Bone Growth Stimulators are a noninvasive device that emits low-intensity pulsed ultrasound. In order to encourage fracture healing, an ultrasonic signal is given to the skin surface at the fracture area using ultrasound conductive coupling gel. When an ultrasonic accelerated fracture healing device is applied over a fracture site, it generates an ultrasonic wave that applies mechanical pressure to the bone tissue at the fracture site. Although the mechanism by which the low-intensity pulsed ultrasonic device stimulates bone formation is uncertain, it is thought to promote bone formation in a manner similar to bone reactions to mechanical stress.By Application, Spinal Fusion Surgery segments are performed to permanently connect two or more bones and eliminate movement between them. Bone growth stimulation products are used to stimulate the natural bone growth process during or after surgery. The growing senior population, the increasing number of spine surgeries, the known safety and effectiveness of stimulators in fusion surgery, and the increasing usage of bone growth stimulation devices all contribute to the growth of Application segment over the forecast period.

By End-User, the Hospitals segment accounted for the majority of the bone growth stimulator revenue in 2022. In hospitals, bone growth stimulation devices are utilized for a variety of purposes including spine surgery, oral and maxillofacial surgery, dental treatments, and bone fractures. In 2022, hospitals and ASCs held the greatest proportion of the bone growth stimulators market. The advantages of bone growth stimulation products over their competitors, the growing patient population, the increasing procedural volumes of spinal fusion surgeries, the rising numbers of spinal disorders, and the growing awareness of bone growth stimulation brands are the key factors driving the growth of the bone growth stimulators market for hospitals and ASCs.
Bone Growth Stimulator Market Regional Insights:
North America dominated the bone growth stimulator market in 2022. North America's strong position in the market may be attributed to the region's highly established healthcare infrastructure and reimbursement system, as well as increased physician and patient awareness of newly launched treatment processes and technologies in the market. The growing cases of spinal problems, an older population, increased exposure to key risk factors (such as obesity, smoking, and diabetes), and growing patient desire for minimally invasive orthopedic therapy are all driving the growth of the bone growth stimulators market in this region.

In Asia Pacific Region, the Bone Growth Stimulator Market is expected to grow at the highest rate owing to the rising number of traffic accidents and the development of healthcare facilities in Asian countries such as China, India, and Indonesia.

The objective of the report is to present a comprehensive analysis of the Bone Growth Stimulator market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Bone Growth Stimulator market dynamics, and structure by analyzing the market segments and projecting the Bone Growth Stimulator market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Bone Growth Stimulator market make the report investor’s guide.
Bone Growth Stimulator Market Scope: Inquire before buying



Global Bone Growth Stimulator Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $1.19 Bn.


Forecast Period 2023 to 2029 CAGR:
6.5%
Market Size in 2029:
US $ 1.82 Bn.


 Segments Covered:
by Product
Bone Growth Stimulation Devices
External Bone Growth Stimulators
Combined Magnetic Field (CMF) Devices
Capacitive Coupling (CC) Devices
Pulsed Electromagnetic Field (PEMF) Devices
Implanted Bone Growth Stimulators
Ultrasonic Bone Growth Stimulators
Bone Morphogenetic Proteins (BMP)
Platelet-rich Plasma (PRP)


by Application
Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral and Maxillofacial Surgeries
Other Applications


by End-User
Hospitals and Clinics
Home Care
Academic & Research Institutes and CRO



Bone Growth Stimulator Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Bone Growth Stimulator Market, Key Players
1. Orthofix International N.V.
2. Medtronic plc
3. Zimmer Biomet Holdings, Inc.
4. DJO Finance LLC
5. Bioventus LLC
6. Stryker Corporation
7. DePuy Synthes
8. Arthrex, Inc.
9. Isto Biologics
10.Harvest Technologies Corporation
11.Ossatak Benelux BV
12.IGEA S.p.a
13.Bioventus
14.Elizer Corporation
15.Wright Medical Group N.V.
16.Prospec-Tany Technogene
17.Orchid Medical Centre
18.TERUMO BCT, INC.
19.Isto Biologics
20.Therapeutics.
21.Regen Lab SA
22.Smith & Nephew

FAQs:

1. Which is the potential market for the Bone Growth Stimulator in terms of the region?
Ans. In the APAC region, the rising number of traffic accidents and the development of healthcare facilities is a key driver for the Bone Growth Stimulator in terms of the region.

2. What is the restraint for the Bone Growth Stimulator market?
Ans. The limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products will impede the market growth.

3. What is expected to drive the growth of the Bone Growth Stimulator market in the forecast period?
Ans. The introduction of innovative bone growth stimulation technologies is expected to boost market revenue.

4. What is the projected market size & growth rate of the Bone Growth Stimulator Market?
Ans. Bone Growth Stimulator Market size was valued at US$ 1.19 Bn. in 2022 and the total Bone Growth Stimulator revenue is expected to grow at 6.5 % through 2022 to 2029, reaching nearly US$ 1.82 Bn.

5. What segments are covered in the Bone Growth Stimulator Market report?
Ans. The segments covered are Product, End User, Application, and Region.